Weight loss drugs are more likely to be covered on government-funded insurance than on private plansByBruce GilUpdatedNovember 18, 2024
Organic carrots are being recalled all over the U.S. in a deadly E. coli outbreakByBruce GilUpdatedNovember 18, 2024
A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drugByBruce GilPublishedNovember 18, 2024
Disney says it's not bailing on traditional TV yet. Its rivals mightByBruce GilPublishedNovember 15, 2024
Amazon and Big Media are discovering that free streaming is a mixed bagByBruce GilPublishedNovember 15, 2024
Amazon is getting into the hair loss and erectile dysfunction businessByBruce GilUpdatedNovember 15, 2024
Disney is looking to replace CEO Bob Iger. Here's who might succeed himByBruce GilUpdatedNovember 13, 2024
Costco is recalling almost 80,000 pounds of butter because apparently people don't know butter has milkByBruce GilUpdatedNovember 12, 2024
4 streaming services people cancel the least — and 5 they're more likely to pauseByBruce GilUpdatedNovember 11, 2024
Forget canceling Netflix: More people are just pausing streaming subscriptions instead of quittingByBruce GilPublishedNovember 11, 2024
Tesla just hit a $1 trillion market cap as Trump's win powers a stock surgeByBruce Gil and William GavinUpdatedNovember 8, 2024
Netflix, Disney+, Hulu, and 5 other major streaming services ranked by priceByBruce GilPublishedNovember 8, 2024
A stronger Ozempic, Wegovy sales boom, and Hims' generic weight loss drug: Pharma news roundupByBruce GilPublishedNovember 8, 2024
The FDA wants to ban a common ingredient in over-the-counter cold and allergy medicationsByBruce GilPublishedNovember 7, 2024
